Skip to main content
RXRX logo

RXRX · Recursion Pharmaceuticals, Inc.

$2.96 -0.05 (-1.66%) At close · Jul 24
Market Cap
$1.57B
Shares
529.91M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 344
Total Value: $986,460,588
Total Shares: 320,971,359
Showing 1–100 of 355 holdings by value · page 1 of 4

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 339 13F filers
Top Holder
13.5%
Jun 2023 → Mar 2026 · range 10.9% – 19.6%
of institutional value
Top 5
49.2%
Jun 2023 → Mar 2026 · range 41.3% – 52.3%
of institutional value
Top 10
64.8%
Jun 2023 → Mar 2026 · range 59.6% – 71.6%
of institutional value
HHI
603
Jun 2023 → Mar 2026 · range 493 – 760
Broadly held
Showing 100 of 355
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1601830 CUSIP 75629V104 13F (30d) 60 filings 60 filers Visit website Investor relations